In close ties with the German Hodgkin Study Group (GHSG) we archive biomaterials from Hodgkin lymphoma patients within GHSG clinical trials. Building on this large collection of materials we are conducting translational studies to deepen our understanding of Hodgkin lymphoma biology. Exemplary, we have recently developed a biological classification of Hodgkin lymphoma based on circulating tumor DNA sequencing.
Building on that, we are further investigating how these subtypes differ in terms of clinical and tumor microenvironmental features. Additionally, we are investigating various biomarkers that might help to
to identify Hodgkin lymphoma patients who might exceptionally benefit from checkpoint inhibition
Building on that, we are further investigating how these subtypes differ in terms of clinical and tumor microenvironmental features. Additionally, we are investigating various biomarkers that might help to
to identify Hodgkin lymphoma patients who might exceptionally benefit from checkpoint inhibition